CRDF
Cardiff Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.09
+0.93%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 316.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.20x
- Price / sales
- 166.92x
- Price / cash flow
- -2.08x
Enterprise value
- Enterprise value
- $50.7M
- EV / sales
- 99.87x
- EV / EBITDA
- -1.30x
- EV / EBIT
- -1.20x
- Market cap
- $84.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026